134 related articles for article (PubMed ID: 29708329)
1. Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe.
Yan H; Gao X; Zhang Y; Chang W; Li J; Li X; Du Q; Li C
ACS Appl Mater Interfaces; 2018 May; 10(20):17047-17057. PubMed ID: 29708329
[TBL] [Abstract][Full Text] [Related]
2. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Endoglin Aptamer Nanoprobe for Targeted Diagnosis of Solid Tumor.
Zhong L; Zou H; Huang Y; Gong W; He J; Tan J; Lai Z; Li Y; Zhou C; Zhang G; Li G; Yang N; Zhao Y
J Biomed Nanotechnol; 2019 Feb; 15(2):352-362. PubMed ID: 30596557
[TBL] [Abstract][Full Text] [Related]
4. An NIR-II/MR dual modal nanoprobe for liver cancer imaging.
Ren Y; He S; Huttad L; Chua MS; So SK; Guo Q; Cheng Z
Nanoscale; 2020 Jun; 12(21):11510-11517. PubMed ID: 32428058
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
7. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.
Yan H; Wang L; Wang J; Weng X; Lei H; Wang X; Jiang L; Zhu J; Lu W; Wei X; Li C
ACS Nano; 2012 Jan; 6(1):410-20. PubMed ID: 22148835
[TBL] [Abstract][Full Text] [Related]
8. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
Maiwald B; Lobsien D; Kahn T; Stumpp P
PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
[TBL] [Abstract][Full Text] [Related]
9. Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma.
Chen Y; Zhou Q; Li X; Wang F; Heist K; Kuick R; Owens SR; Wang TD
Bioconjug Chem; 2017 Nov; 28(11):2794-2803. PubMed ID: 28972742
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.
Guo J; Seo Y; Ren S; Hong S; Lee D; Kim S; Jiang Y
Abdom Radiol (NY); 2016 Oct; 41(10):1960-72. PubMed ID: 27318936
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
Jin Y; Wang K; Tian J
Bioconjug Chem; 2018 Apr; 29(4):1475-1484. PubMed ID: 29544252
[TBL] [Abstract][Full Text] [Related]
12. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
14. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
[TBL] [Abstract][Full Text] [Related]
15. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Detection and Intraoperative Visualization of Brain Tumors for More Precise Surgery: A New Dual-Modality MRI and NIR Nanoprobe.
Li C; Cao L; Zhang Y; Yi P; Wang M; Tan B; Deng Z; Wu D; Wang Q
Small; 2015 Sep; 11(35):4517-25. PubMed ID: 26058947
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
19. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
20. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
